73 related articles for article (PubMed ID: 23267890)
21. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
Kawakami Y; Nabeshima S; Furusyo N; Sawayama Y; Hayashi J; Kashiwagi S
Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
[TBL] [Abstract][Full Text] [Related]
22. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer.
Zhuang Y; Peng LS; Zhao YL; Shi Y; Mao XH; Chen W; Pang KC; Liu XF; Liu T; Zhang JY; Zeng H; Liu KY; Guo G; Tong WD; Shi Y; Tang B; Li N; Yu S; Luo P; Zhang WJ; Lu DS; Yu PW; Zou QM
Gastroenterology; 2012 Oct; 143(4):951-62.e8. PubMed ID: 22710190
[TBL] [Abstract][Full Text] [Related]
23. Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia.
Aswald JM; Lipton JH; Messner HA
Cytokines Cell Mol Ther; 2002 Dec; 7(2):75-82. PubMed ID: 12607798
[TBL] [Abstract][Full Text] [Related]
24. IFN-γ producing T cells contribute to the increase of myeloid derived suppressor cells in tumor-bearing mice after cyclophosphamide treatment.
Guo Q; Lv Z; Fu Q; Jiang C; Liu Y; Lai L; Chen Q; Shen J; Wang Q
Int Immunopharmacol; 2012 Feb; 12(2):425-32. PubMed ID: 22226750
[TBL] [Abstract][Full Text] [Related]
25. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
26. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
[TBL] [Abstract][Full Text] [Related]
27. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine.
Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY
J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
[TBL] [Abstract][Full Text] [Related]
29. Serum Soluble Interleukin-2 Receptor is Increased in Malnourished and Immunosuppressed Patients With Gastric and Colorectal Cancer: Possible Influence of Myeloid-Derived Suppressor Cells.
Gonda K; Shibata M; Shimura T; Machida T; Suzuki S; Nakamura I; Ohki S; Sakurai K; Ohto H; Tomita R; Takenoshita S
World J Oncol; 2012 Aug; 3(4):158-164. PubMed ID: 29147299
[TBL] [Abstract][Full Text] [Related]
30. Identification of myeloid-derived suppressor cells and T regulatory cells in lung microenvironment after Urethane-induced lung tumor.
Rosin FC; Pedregosa JF; de Almeida JS; Bueno V
Int Immunopharmacol; 2011 Jul; 11(7):873-8. PubMed ID: 21238620
[TBL] [Abstract][Full Text] [Related]
31. Th1 polarization and low-T3 syndrome are correlated with hyperleptinemia in hemodialysis patients.
Liu ML; Huang ZY; Zhong XC; Liu SH; Xu G; Jiang TY; Xi WW; Yan WQ
J Nephrol; 2009; 22(4):515-22. PubMed ID: 19662608
[TBL] [Abstract][Full Text] [Related]
32. [Expression of myeloid-derived suppressor cells in the peripheral blood and its clinical significance in renal carcinoma].
Feng S; Liu C; Zheng S; Huang P; Chen B; Guo K
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):550-3. PubMed ID: 23644118
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant.
Fernández A; Mesa C; Marigo I; Dolcetti L; Clavell M; Oliver L; Fernández LE; Bronte V
J Immunol; 2011 Jan; 186(1):264-74. PubMed ID: 21135171
[TBL] [Abstract][Full Text] [Related]
34. Expression and significance of peripheral myeloid-derived suppressor cells in chronic hepatitis B patients.
Lv Y; Cui M; Lv Z; Lu J; Zhang X; Zhao Z; Wang Y; Gao L; Tsuji NM; Yan H
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):462-469. PubMed ID: 29753730
[TBL] [Abstract][Full Text] [Related]
35. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
Nagamine I; Yamaguchi Y; Ohara M; Ikeda T; Okada M
Hiroshima J Med Sci; 2009 Mar; 58(1):37-44. PubMed ID: 19400555
[TBL] [Abstract][Full Text] [Related]
36. Myeloid-derived suppressor cell role in tumor-related inflammation.
Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
[TBL] [Abstract][Full Text] [Related]
37. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression.
Zhang M; Liu Q; Mi S; Liang X; Zhang Z; Su X; Liu J; Chen Y; Wang M; Zhang Y; Guo F; Zhang Z; Yang R
J Immunol; 2011 Apr; 186(8):4716-24. PubMed ID: 21383238
[TBL] [Abstract][Full Text] [Related]
38. Transcription factors in myeloid-derived suppressor cell recruitment and function.
Sonda N; Chioda M; Zilio S; Simonato F; Bronte V
Curr Opin Immunol; 2011 Apr; 23(2):279-85. PubMed ID: 21227670
[TBL] [Abstract][Full Text] [Related]
39. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
